Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

A Comparative Study of Degarelix Three-month Depot in Three Different Dosing Regimens in Patients With Prostate Cancer

ClinicalTrials.gov ID: NCT00116753

Public ClinicalTrials.gov record NCT00116753. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 4, 2026, 11:12 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

An Open-label Multi-center, Randomized Parallel Group Comparison of Efficacy and Safety of Degarelix Three-Month Depot in Three Different Dosing Regimens in Patients With Prostate Cancer

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The rationale of the study was to evaluate different degarelix dosing regimens for a three-month interval that was to produce and maintain castration in prostate cancer patients through immediate and prolonged testosterone suppression, and to provide confirmatory evidence of the safety of degarelix.

Study identification

NCT ID
NCT00116753
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Ferring Pharmaceuticals
Industry
Enrollment
460 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
Male
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 31, 2004
Primary completion
Oct 31, 2006
Completion
Oct 31, 2006
Last update posted
Dec 9, 2010

2005 – 2006

United States locations

U.S. sites
23
U.S. states
13
U.S. cities
22
Facility City State ZIP Site status
Urology Centers of Alabama Homewood Alabama 35209
Medical Affiliationed Research Center Huntsville Alabama 35801
Alaska Clinical Research Center, LLC Anchorage Alaska 99508
Advanced Urology Medical Center Anaheim California 92801
Center for Urological Research La Mesa California 91942
South Orange County Medical Research Center Laguna Woods California 92653
West Coast Clinical Research Tarzana California 91356
Western Clinical Research Torrance California 90505
Urology Research Option Aurora Colorado 80012
South Florida Medical Research Aventura Florida 33180
RT Services, Inc Fort Myers Florida 33901
SW Florida Urological Associates Fort Myers Florida 33907
Regional Urology Shreveport Louisiana 71106
Mississippi Urology Clinic Jackson Mississippi 39202
University of Missouri, Urology, Deptof Surgery Columbia Missouri 65212
Kansas City Urology Care Kansas City Missouri 64131
Northeast Urology Research Concord North Carolina 28025
The Urology Center Greensboro North Carolina 27401
State College Urologic Association State College Pennsylvania 16801
Grand Strand Urology Myrtle Beach South Carolina 29572
Urology Association of Northern Texas Fort Worth Texas 76104
Urology San Antonio Research San Antonio Texas 78229
Seatle Urology Research Centre Seattle Washington 98166

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 33 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00116753, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Dec 9, 2010 · Synced Sep 4, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00116753 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →